Eisai Co

Eisai Co EBIT

The EBIT of Eisai Co (4523.T) as of Oct 30, 2026 is 40.21 B JPY. In the previous year, EBIT was 49.24 B JPY — a change of -18.34% (lower).

EBIT

40.21 BJPY

YoY

-18.34%

Last updated:

In 2026, Eisai Co's EBIT was 40.21 B JPY, a -18.34% increase from the 49.24 B JPY EBIT recorded in the previous year.

The Eisai Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2024
46.75 B JPY
Jan 1, 2025
49.24 B JPY
Jan 1, 2026
40.21 B JPY
Jan 1, 2027 (e)
72.75 B JPY
Jan 1, 2028 (e)
83.31 B JPY
Jan 1, 2029 (e)
84.85 B JPY
Jan 1, 2030 (e)
99.56 B JPY
Jan 1, 2031 (e)
112.38 B JPY
The Eisai Co EBIT history
YEAREBITYoY
est112.38 BJPY+12.87%
est99.56 BJPY+17.34%
est84.85 BJPY+1.85%
est83.31 BJPY+14.52%
est72.75 BJPY+80.93%
40.21 BJPY-18.34%
49.24 BJPY+5.32%
46.75 BJPY+19.20%
39.22 BJPY-34.22%
59.62 BJPY+5.45%
56.54 BJPY-59.23%
138.68 BJPY+38.79%
99.92 BJPY+32.18%
75.60 BJPY+47.63%
51.21 BJPY+19.70%
42.78 BJPY+54.00%
27.78 BJPY-56.85%
64.37 BJPY-8.64%
70.46 BJPY-26.41%
95.75 BJPY-15.35%
113.12 BJPY+30.91%
86.41 BJPY-5.88%
91.81 BJPY+417.26%
17.75 BJPY-83.14%
105.26 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Eisai Co Revenue

Eisai Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
741.75 B JPY
46.75 B JPY
42.41 B JPY
Jan 1, 2025
789.40 B JPY
49.24 B JPY
46.43 B JPY
Jan 1, 2026
825.38 B JPY
40.21 B JPY
38.56 B JPY
Jan 1, 2027 (e)
911.99 B JPY
72.75 B JPY
56.81 B JPY
Jan 1, 2028 (e)
973.14 B JPY
83.31 B JPY
68.00 B JPY
Jan 1, 2029 (e)
997.64 B JPY
84.85 B JPY
68.46 B JPY
Jan 1, 2030 (e)
1.00 T JPY
99.56 B JPY
79.05 B JPY
Jan 1, 2031 (e)
1.03 T JPY
112.38 B JPY
89.57 B JPY

Eisai Co Margins

Eisai Co stock margins

The Eisai Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Eisai Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Eisai Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
76.01 %
6.30 %
5.72 %
Jan 1, 2025
75.66 %
6.24 %
5.88 %
Jan 1, 2026
76.83 %
4.87 %
4.67 %
Jan 1, 2027 (e)
76.83 %
7.98 %
6.23 %
Jan 1, 2028 (e)
76.83 %
8.56 %
6.99 %
Jan 1, 2029 (e)
76.83 %
8.50 %
6.86 %
Jan 1, 2030 (e)
76.83 %
9.95 %
7.90 %
Jan 1, 2031 (e)
76.83 %
10.90 %
8.69 %

Eisai Co Stock analysis

What does Eisai Co do? Eisai Co Ltd is a Japanese pharmaceutical company based in Tokyo that specializes in research, development, production, and marketing of pharmaceuticals. The company was founded in 1936 by Shinjiro Torii, who had previously worked as a chemist at another pharmaceutical company. Eisai began its journey in the production of medicines, especially herbal medicine known in Japan, which are sold as OTC products. Eisai grew rapidly and started producing antibiotics in 1947. Over the following decades, the company expanded into the global market and is now present in over 20 countries. Eisai is dedicated to creating innovations as its main business model in order to help patients worldwide through its range of products. With this mission, the company has developed and introduced hundreds of drugs to the market, improving the quality of life for millions of people around the world. The company is divided into several business segments, including neurology, oncology, coagulation disorders, and gastrointestinal diseases. Eisai specializes in developing innovative drugs targeting a wide range of human diseases. Eisai is particularly known today for its leading position in Alzheimer's and dementia research. An important milestone in the company's history was the discovery of Aricept, a medication used to treat Alzheimer's disease. Eisai was the first Japanese company to develop a drug approved by the US FDA. Other products from Eisai include Lenvima, a medication for the treatment of thyroid cancer, and Lusedra, a sedative for anesthesia induction and maintenance for patients undergoing surgery. Eisai invests significantly in research and development to maintain its position as an innovation leader in the pharmaceutical manufacturing industry. The company collaborates with leading academic institutions and research organizations to make groundbreaking discoveries in various medical fields. Eisai also places importance on social responsibility and is involved in numerous social projects such as supporting Japan against cancer and providing consultation for elderly home care. The company aims to contribute to making the healthcare system more sustainable and equitable. Overall, Eisai is a leading pharmaceutical company with a strong focus on creating innovations to improve human health. It has a wide range of products and continuously works on developing new drugs and therapies to help patients worldwide. Eisai Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Eisai Co's EBIT

Eisai Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Eisai Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Eisai Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Eisai Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Eisai Co stock

EBIT of Eisai Co is 40.21 B JPY in 2026.

EBIT of Eisai Co changed from 49.24 B JPY to 40.21 B JPY, representing a -18.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Eisai Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Eisai Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Eisai Co

All Key Metrics — Eisai Co